SCHEMBL31031282

SCHEMBL31031282

CCSCCN(CCSCC)Cc1nccn1CCOCCOCCOCCOCCOCCN=[N+]=[N-]

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MGMT P16455 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31031273 0.81 MGMT (0.40) MGMT
SCHEMBL17723266 0.74 MGMT (0.38) MGMT
SCHEMBL28782143 0.66 CA12 (0.44) MGMT
SCHEMBL9866875 0.63 ADORA2A (0.34)
SCHEMBL13587988 0.59 TLR8 (0.39)
SCHEMBL11155334 0.59 TLR8 (0.46)
SCHEMBL9866983 0.59 ADORA2A (0.33)
SCHEMBL20383096 0.59 MGMT (0.37) MGMT
SCHEMBL9867208 0.59 SIGMAR1 (0.34)
SCHEMBL8367322 0.58 ADORA2A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4652160-A1 COMPOUNDS FOR NUCLEIC ACID CLEAVAGE Cambridge Enterprise Limited (GB) 2025-11-26 EP disclosed
WO-2024153950-A1 COMPOUNDS FOR NUCLEIC ACID CLEAVAGE CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-07-25 WO disclosed
WO-2024153952-A1 COMPOUNDS FOR NUCLEIC ACID CLEAVAGE CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-07-25 WO disclosed